Carboxypeptidase B

Handbook of Proteolytic Enzymes

Volumn 1, Issue , 2013, Pages 1324-1329

  Avilés, Francesc X ^a   Vendrell, Josep ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884823347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382219-2.00297-0     Document Type: Chapter

References (70)

1. Folk J.E., Piez K.A., Carroll W.R., Gladner J.A. Carboxypeptidase B. IV. Purification and characterization of the porcine enzyme. J. Biol. Chem. 1960, 235:2272-2277.
2. Eaton D.L., Malloy B.E., Tsai S.P., Henzel W., Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 1991, 266(32):21833-21838.
3. Arolas J.L., Vendrell J., Aviles F.X., Fricker L.D. Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr. Pharm. Des. 2007, 13(4):349-366.
4. Rawlings N.D., Barrett A.J., Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010, 38(Database issue):D227-D233.
5. Skidgel R.A. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol. Sci. 1988, 9(8):299-304.
6. Reznik S.E., Fricker L.D. Carboxypeptidases from A to z: implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 2001, 58(12-13):1790-1804.
7. McKay T.J., Phelan A.W., Plummer T.H. Comparative studies on human carboxypeptidases B and N. Arch. Biochem. Biophys. 1979, 197(2):487-492.
8. Nishihira J., Hibiya Y., Sakai M., Nishi S., Kumazaki T., Ohki S., Sakamoto W. The C-terminal region, Arg201-Gln209, of glutathione S-transferase P contributes to stability of the active-site conformation. Biochim. Biophys. Acta 1995, 1252(2):233-238.
9. Villegas V., Vendrell J., Aviles X. The activation pathway of procarboxypeptidase B from porcine pancreas: participation of the active enzyme in the proteolytic processing. Protein Sci. 1995, 4(9):1792-1800.
10. Tan A.K., Eaton D.L. Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry 1995, 34(17):5811-5816.
11. Mock W.L., Stanford D.J. Anisylazoformylarginine: a superior assay substrate for carboxypeptidase B type enzymes. Bioorg. Med. Chem. Lett. 2002, 12(8):1193-1194.
12. Mock W.L., Xu D. Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates. Bioorg. Med. Chem. Lett. 1999, 9(2):187-192.
13. Plummer T.H., Ryan T.J. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem. Biophys. Res. Commun. 1981, 98(2):448-454.
14. Ondetti M.A., Condon M.E., Reid J., Sabo E.F., Cheung H.S., Cushman D.W. Design of potent and specific inhibitors of carboxypeptidases A and B. Biochemistry 1979, 18(8):1427-1430.
15. Anand K., Pallares I., Valnickova Z., Christensen T., Vendrell J., Wendt K.U., Schreuder H.A., Enghild J.J., Aviles F.X. The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa. J. Biol. Chem. 2008, 283(43):29416-29423.
16. Barbosa Pereira P.J., Segura-Martin S., Oliva B., Ferrer-Orta C., Aviles F.X., Coll M., Gomis-Ruth F.X., Vendrell J. Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI). J. Mol. Biol. 2002, 321(3):537-547.
17. Fernandez D., Aviles F.X., Vendrell J. Aromatic organic compounds as scaffolds for metallocarboxypeptidase inhibitor design. Chem. Biol. Drug Des. 2009, 73(1):75-82.
18. Fernandez D., Aviles F.X., Vendrell J. A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases. Eur. J. Med. Chem. 2009, 44(8):3266-3271.
19. Fernandez D., Torres E., Aviles F.X., Ortuno R.M., Vendrell J. Cyclobutane-containing peptides: Evaluation as novel metallocarboxypeptidase inhibitors and modelling of their mode of action. Bioorg. Med. Chem. 2009, 17(11):3824-3828.
20. Adler M., Buckman B., Bryant J., Chang Z., Chu K., Emayan K., Hrvatin P., Islam I., Morser J., Sukovich D., West C., Yuan S., Whitlow M. Structures of potent selective peptide mimetics bound to carboxypeptidase B. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2008, 64:149-157.
21. Fernandez D., Illa O., Aviles F.X., Branchadell V., Vendrell J., Ortuno R.M. Thioxophosphoranyl aryl- and heteroaryloxiranes as the representants of a new class of metallocarboxypeptidase inhibitors. Bioorg. Med. Chem. 2008, 16(9):4823-4828.
22. Adler M., Bryant J., Buckman B., Islam I., Larsen B., Finster S., Kent L., May K., Mohan R., Yuan S.D., Whitlow M. Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B. Biochemistry 2005, 44(26):9339-9347.
23. Fernandez D., Pallares I., Vendrell J., Aviles F.X. Progress in metallocarboxypeptidases and their small molecular weight inhibitors. Biochimie 2010, 92(11):1484-1500.
24. Hass G.M., Ryan C.A. Cleavage of the carboxypeptidase inhibitor from potatoes by carboxypeptidase A. Biochem. Biophys. Res. Commun. 1980, 97(4):1481-1486.
25. Reverter D., Vendrell J., Canals F., Horstmann J., Aviles F.X., Fritz H., Sommerhoff C.P. A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J. Biol. Chem. 1998, 273(49):32927-32933.
26. Arolas J.L., Lorenzo J., Rovira A., Castella J., Aviles F.X., Sommerhoff C.P. A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization. J. Biol. Chem. 2005, 280(5):3441-3448.
27. Buchanan M.S., Carroll A.R., Edser A., Sykes M., Fechner G.A., Forster P.I., Guymer G.P., Quinn R.J. Lysianadioic acid, a carboxypeptidase B inhibitor from Lysiana subfalcata. Bioorg. Med. Chem. Lett. 2008, 18(4):1495-1497.
28. Borch J., Roepstorff P. Screening for enzyme inhibitors by surface plasmon resonance combined with mass spectrometry. Anal. Chem. 2004, 76(18):5243-5248.
29. Aviles F.X., Vendrell J., Guasch A., Coll M., Huber R. Advances in metallo-procarboxypeptidases. Emerging details on the inhibition mechanism and on the activation process. Eur. J. Biochem. 1993, 211(3):381-389.
30. Titani K., Ericsson L.H., Walsh K.A., Neurath H. Amino-acid sequence of bovine carboxypeptidase B. Proc. Natl. Acad. Sci. USA 1975, 72(5):1666-1670.
31. Schmid M.F., Herriott J.R. Structure of carboxypeptidase B at 2-8 Å resolution. J. Mol. Biol. 1976, 103(1):175-190.
32. Coll M., Guasch A., Aviles F.X., Huber R. Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity. EMBO J. 1991, 10(1):1-9.
33. Fernandez D., Boix E., Pallares I., Aviles F.X., Vendrell J. Analysis of a new crystal form of procarboxypeptidase B: further insights into the catalytic mechanism. Biopolymers 2010, 93(2):178-185.
34. García-Sáez I., Reverter D., Vendrell J., Avilés F.X., Coll M. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen. EMBO J. 1997, 16(23):6906-6913.
35. Cho J.H., Kim D.H., Lee K.J., Choi K.Y. The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A. Biochemistry 2001, 40(34):10197-10203.
36. Gardell S.J., Hilvert D., Barnett J., Kaiser E.T., Rutter W.J. Use of directed mutagenesis to probe the role of tyrosine 198 in the catalytic mechanism of carboxypeptidase A. J. Biol. Chem. 1987, 262(2):576-582.
37. Fernandez D., Boix E., Pallares I., Aviles F.X., Vendrell J. Analysis of a new crystal form of procarboxypeptidase B: Further insights into the catalytic mechanism. Biopolymers 2010, 93(2):178-185.
38. Marx P.F., Brondijk T.H., Plug T., Romijn R.A., Hemrika W., Meijers J.C., Huizinga E.G. Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Blood 2008, 112(7):2803-2809.
39. Sanglas L., Valnickova Z., Arolas J.L., Pallares I., Guevara T., Sola M., Kristensen T., Enghild J.J., Aviles F.X., Gomis-Ruth F.X. Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis. Mol. Cell 2008, 31(4):598-606.
40. Billeter M., Vendrell J., Wider G., Aviles F.X., Coll M., Guasch A., Huber R., Wuthrich K. Comparison of the NMR solution structure with the X-ray crystal structure of the activation domain from procarboxypeptidase B. J. Biomol. NMR 1992, 2(1):1-10.
41. Pascual R., Burgos F.J., Salva M., Soriano F., Mendez E., Aviles F.X. Purification and properties of five different forms of human procarboxypeptidases. Eur. J. Biochem. 1989, 179(3):609-616.
42. Brodrick J.W., Geokas M.C., Largman C. Human carboxypeptidase B. II. Purification of the enzyme from pancreatic tissue and comparison with the enzymes present in pancreatic secretion. Biochim. Biophys. Acta 1976, 452(2):468-481.
43. Reeck G.R., Neurath H. Isolation and characterization of pancreatic procarboxypeptidase B and carboxypeptidase B of the African lungfish. Biochemistry 1972, 11(21):3947-3955.
44. Reeck G.R., Walsh K.A., Hermodson M.A., Neurath H. New forms of bovine carboxypeptidase B and their homologous relationships to carboxypeptidase A. Proc. Natl. Acad. Sci. USA 1971, 68(6):1226-1230.
45. Burgos F.J., Pascual R., Vendrell J., Cuchillo C.M., Aviles F.X. The separation of pancreatic procarboxypeptidases by high-performance liquid chromatography and chromatofocusing. J. Chromatogr. 1989, 481:233-243.
46. Bradley G., Naude R.J., Muramoto K., Yamauchi F., Oelofsen W. Ostrich (Struthio camelus) carboxypeptidase B: purification, kinetic properties and characterization of the pancreatic enzyme. Int. J. Biochem. Cell Biol. 1996, 28(5):521-529.
47. Kishimura H., Hayashi K. Isolation and characteristics of carboxypeptidase B from the pyloric ceca of the starfish Asterias amurensis. Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 2002, 133(2):183-189.
48. Yamamoto K.K., Pousette A., Chow P., Wilson H., el Shami S., French C.K. Isolation of a cDNA encoding a human serum marker for acute pancreatitis. Identification of pancreas-specific protein as pancreatic procarboxypeptidase B. J. Biol. Chem. 1992, 267(4):2575-2581.
49. Burgos F.J., Salva M., Villegas V., Soriano F., Mendez E., Aviles F.X. Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment. Biochemistry 1991, 30(16):4082-4089.
50. Kim M.J., Kim M.-J., Lee J.H., Kim Y.-H., Se J.-H., Nam S.-W. Secretory overexpression and characterization of human procarboxypeptidase B from Saccharomyces cerevisiae. Korean Journal of Microbiology and Biotechnology 2008, 36(1):49-54.
51. Mi-Jin K., Kim S.H., Lee J.H., Seo J.H., Kim J.H., Kim Y.H., Nam S.W. High-level secretory expression of human procarboxypeptidase B by fed-batch cultivation of Pichia pastoris and its partial characterization. J. Microbiol. Biotechn. 2008, 18(12):1938-1944.
52. Ventura S., Villegas V., Sterner J., Larson J., Vendrell J., Hershberger C.L., Aviles F.X. Mapping the pro-region of carboxypeptidase B by protein engineering. Cloning, overexpression, and mutagenesis of the porcine proenzyme. J. Biol. Chem. 1999, 274(28):19925-19933.
53. Clauser E., Gardell S.J., Craik C.S., MacDonald R.J., Rutter W.J. Structural characterization of the rat carboxypeptidase A1 and B genes. Comparative analysis of the rat carboxypeptidase gene family. J. Biol. Chem. 1988, 263(33):17837-17845.
54. Szmola R., Bence M., Carpentieri A., Szabo A., Costello C.E., Samuelson J., Sahin-Toth M. Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. J. Biol. Chem. 2011, 286(3):1819-1827.
55. Appelros S., Borgstrom A. Studies on the turnover of procarboxypeptidase B, its active enzyme and the activation peptide in the pig. Biol. Chem. 1998, 379(7):893-898.
56. Appelros S., Petersson U., Toh S., Johnson C., Borgstrom A. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Brit. J. Surg. 2001, 88(2):216-221.
57. Hjalmarsson C., Stenflo J., Borgstrom A. Activated protein C-protein C inhibitor complex, activation peptide of carboxypeptidase B and C-reactive protein as predictors of severe acute pancreatitis. Pancreatology 2009, 9(5):700-707.
58. Abu Hilal M., Ung C.T., Westlake S., Johnson C.D. Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. J. Gastroen. Hepatol. 2007, 22(3):349-354.
59. Muller C.A., Appelros S., Uhl W., Buchler M.W., Borgstrom A. A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Pancreatology 2003, 3(2):149-155.
60. Borgstrom A., Regner S. Active carboxypeptidase B is present in free form in serum from patients with acute pancreatitis. Pancreatology 2005, 5(6):530-536.
61. Docherty K., Hutton J.C. Carboxypeptidase activity in the insulin secretory granule. FEBS Lett. 1983, 162(1):137-141.
62. Kemmler W., Peterson J.D., Steiner D.F. Studies on the conversion of proinsulin to insulin. I. Conversion in vitro with trypsin and carboxypeptidase B. J. Biol. Chem. 1971, 246(22):6786-6791.
63. Son Y.J., Kim C.K., Kim Y.B., Kweon D.H., Park Y.C., Seo J.H. Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B. Biotechnol. Prog. 2009, 25(4):1064-1070.
64. Vovchuk I.L., Chernadchuk S.S., Petrov S.A. Estrogens, trypsyn-like proteinases and carboxypeptidases A and B at womb body tumors. Biomeditsinskaya Khimiya 2007, 53(2):205-211.
65. Edge M., Forder C., Hennam J., Lee I., Tonge D., Hardern I., Fitton J., Eckersley K., East S., Shufflebotham A., Blakey D., Slater A. Engineered human carboxypeptidase B enzymes that hydrolyse hippuryl-L-glutamic acid: reversed-polarity mutants. Protein Eng. 1998, 11(12):1229-1234.
66. Kawabe T., Sasaki R., Nishimura H., Soejima T., Matsuyama S., Sugimura K., Matsumoto A. Brain-specific carboxypeptidase B: Selective down-regulation in ependymal cell by irradiation and altered beta-amyloid processing. Neurosci. Res. Commun. 2002, 31(2):75-84.
67. Matsumoto A., Itoh K., Matsumoto R. A novel carboxypeptidase B that processes native beta-amyloid precursor protein is present in human hippocampus. Eur. J. Neurosci. 2000, 12(1):227-238.
68. Matsumoto A., Itoh K., Seki T., Motozaki K., Matsuyama S. Human brain carboxypeptidase B, which cleaves beta-amyloid peptides in vitro, is expressed in the endoplasmic reticulum of neurons. Eur. Neurosci. 2001, 13(9):1653-1657.
69. Papp H., Torok I., Matsumoto A., Enomoto T., Matsuyama S., Kasa P. Expression and distribution of carboxypeptidase B in the hippocampal subregions of normal and Alzheimer's disease brain. Acta Biologica Hungarica 2003, 54(1):55-62.
70. Muller C.A., Appelros S., Uhl W., Buchler M.W., Borgstrom A. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002, 51(2):229-235.